“Drug Facts” Box Not Ready For Prime Time, FDA Advisory Cmte. Says
Executive Summary
FDA's Risk Communication Advisory Committee likes the concept of a standardized format in drug promotional labeling and print advertising, but remains concerned that different risk levels for different populations could negate its utility.